Theodore Laetsch
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors (NCT06721689) | Theodore Laetsch | 2025-03-23 |
| HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors (NCT02557854) | Theodore Laetsch | 2016-12-01 |
| A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors (NCT01962896) | Theodore Laetsch | 2014-01-08 |
Track Theodore Laetsch automatically
Every clearance here is in the API, with alerts when new ones post.